Andy Howe is currently the Sr. Director of Quality Assurance at Vir Biotechnology, a position held since 2022. Previously, they served as Sr. Director of Quality Assurance at Catalyst Biosciences from 2018 to 2022 and at Rodan and Fields from 2013 to 2017. Their earlier experience includes roles as Principal Product Quality at Amgen and various director level positions in quality assurance at Affymax, FibroGen, and Abgenix. Andy has a strong background in quality assurance, beginning their career as Sr. Manager of Quality Assurance at Genentech from 1995 to 2002.
This person is not in any teams
This person is not in any offices